|
CNBP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.57749999998946E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.97879999999896E-05 |
| Normal-vs-Stage2 |
1.71365999999118E-05 |
| Normal-vs-Stage3 |
1.7745000000513E-06 |
| Normal-vs-Stage4 |
7.59160000000092E-05 |
| Stage1-vs-Stage2 |
4.058400E-02 |
| Stage1-vs-Stage3 |
1.116810E-01 |
| Stage1-vs-Stage4 |
4.570400E-01 |
| Stage2-vs-Stage3 |
4.196400E-01 |
| Stage2-vs-Stage4 |
2.806200E-01 |
| Stage3-vs-Stage4 |
6.501600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.01180000000589E-06 |
| Normal-vs-AfricanAmerican |
2.192000E-01 |
| Normal-vs-Asian |
2.061200E-03 |
| Caucasian-vs-AfricanAmerican |
4.816500E-02 |
| Caucasian-vs-Asian |
3.096600E-01 |
| AfricanAmerican-vs-Asian |
2.629800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.77852999999617E-05 |
| Normal-vs-Female |
1.61920999999232E-05 |
| Male-vs-Female |
8.308400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.603100E-04 |
| Normal-vs-Age(41-60Yrs) |
4.40459999995202E-06 |
| Normal-vs-Age(61-80Yrs) |
1.27049999998352E-06 |
| Normal-vs-Age(81-100Yrs) |
2.764400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.491800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.511800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.834200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.987400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.603800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.410200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.928400E-01 |
| Classical-VS-Follicular |
2.439200E-04 |
| Classical-VS-Other |
6.460800E-01 |
| Classical-VS-Normal |
3.956000E-04 |
| Tall-VS-Follicular |
7.491700E-02 |
| Tall-VS-Other |
8.690800E-01 |
| Tall-VS-Normal |
5.542200E-03 |
| Follicular-VS-Other |
4.275600E-01 |
| Follicular-VS-Normal |
1.79249999954223E-07 |
| Other-VS-Normal |
8.533800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.86669999966161E-07 |
| Normal-vs-N1 |
1.52863999999253E-05 |
| N0-vs-N1 |
7.879600E-01 |
|
|
